Cervical disc disorder with radiculopathy, mid-cervical region
ICD-10 Code: M50.12 · Body Part: Cervical Spine
QME Evaluation Process
C5-C6 dermatomal testing, biceps and brachioradialis reflex testing, deltoid and biceps strength testing. EMG/NCS for C5-C6 radiculopathy. MRI correlation.
Typical Impairment Rating
10-28% WPI per DRE Category III-V
AMA Guides Edition
5th Edition
Common Treatments
Related Conditions
Body Part Guide
Cervical Spine Evaluation Guide
Impairment rating methods, common conditions, and QME evaluation protocols
QME Specialties for Cervical disc disorder with radiculopathy, mid-cervical region
Find a QME Specialist
Browse QME-certified physicians who evaluate cervical disc disorder with radiculopathy, mid-cervical region and related cervical spine conditions in California.
Browse Neurology Physicians →Frequently Asked Questions
What is Cervical disc disorder with radiculopathy, mid-cervical region (M50.12)?
Cervical disc disorder with radiculopathy, mid-cervical region is an ICD-10 diagnosis code (M50.12) classified under Musculoskeletal conditions. It affects the Cervical Spine and is commonly encountered in California workers' compensation claims. QME physicians evaluate this condition using AMA Guides 5th Edition protocols.
How is M50.12 rated for impairment?
The typical whole person impairment (WPI) range for Cervical disc disorder with radiculopathy, mid-cervical region is 10-28% WPI per DRE Category III-V. The exact rating depends on clinical findings, imaging, and the evaluation method (DRE or ROM) chosen by the QME physician per AMA Guides 5th Edition.
What is the QME evaluation process for M50.12?
C5-C6 dermatomal testing, biceps and brachioradialis reflex testing, deltoid and biceps strength testing. EMG/NCS for C5-C6 radiculopathy. MRI correlation.
What treatments are common for Cervical disc disorder with radiculopathy, mid-cervical region?
Common treatments for Cervical disc disorder with radiculopathy, mid-cervical region include ACDF C5-C6, Cervical epidural injections, Physical therapy. Treatment appropriateness and outcomes are considered during the QME evaluation when determining permanent and stationary status and apportionment.